Previous 10 | Next 10 |
Amarin ( AMRN -3.7% ) is not yet admitting defeat in its patent infringement litigation against would-be generic Vascepa competitors Dr. Reddy's Laboratories ( RDY -0.2% ) and Hikma Pharmaceuticals. More news on: Amarin Corporation plc, Dr. Reddy's Laboratories Limited, Healthcare ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a therap...
Amarin (NASDAQ: AMRN ) is down 10% premarket on robust volume in apparent reaction to reports that judges have been assigned in its appeal of an adverse ruling by a Nevada court opening the gate for generic versions of Vascepa (icosapent ethyl). More news on: Amarin Corporati...
Stocks have a tendency to rally further than anybody thinks, and animal spirits could continue rewarding being long, but rules governing risk control will be key when the music stops, so investors ought to be planning exit strategies now, while the going is good. If they don't, the risk of rea...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Penicillamine Capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine® (pe...
Dr. Reddy’s Laboratories (NYSE: RDY ) announces the launch of Avigan (Favipiravir) 200 mg Tablets in India. The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd. More news on: Dr. Reddy's Laboratories Limited, Healthcare stocks news, ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of AVIGAN ® (Favipiravir) 200 mg Tablets in India. The launch is part of the global licensing ...
The stock market has a way of surprising and our overbought indicator suggests investors banking on uninterrupted gains could be disappointed. Weekly, we track how many of the 1,500 widely-traded stocks in our marketplace universe are trading 5% or higher above their 200-day moving average. ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a therapeutic equivalent generic ve...
Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...